Macrocephaly as a clinical indicator of genetic subtypes in autism.
Macrocephaly as a clinical indicator of genetic subtypes in autism.
复制标题
DOI:
10.1002/aur.1266
复制
发表时间:
2013-02
期刊:
影响因子:
4.7
通讯作者:
Martinez-Agosto, Julian A.
中科院分区:
文献类型:
--
作者:
Klein, Steven;Sharifi-Hannauer, Pantea;Martinez-Agosto, Julian A.
An association between autism and large head size has been previously described. Historically a subset of these cases have been correlated with mutations in the gene phosphatase and tensin homolog (PTEN). However, for the majority of cases the etiology is not known. We have studied 33 patients with autism and large head size. Within this group, we confirm the association of PTEN mutations and extreme head size and identify mutations in 22% of cases, including three novel PTEN mutations. In addition we define three novel phenotypic subgroups: (1) cases associated with somatic overgrowth (2) those with disproportionate macrocephaly and (3) those with relative macrocephaly. Members of these subgroups lack changes in the PTEN gene and furthermore we report two novel copy number changes in these patients. An association between autism and macrocephaly has been previously described. A subset of cases with extreme macrocephaly (>3SD, 99.7th %ile) have been correlated to mutations in the gene phosphatase and tensin homolog (PTEN). However, the phenotypic and genetic characterization of the remaining cases remains unclear. We report the phenotypic classification and genetic testing evaluation of a cohort of 33 patients with autism and macrocephaly. Within our cohort, we confirm the association of PTEN mutations and extreme macrocephaly (> 3SD, 99.7th %ile) and identify mutations in 22% of cases, including three novel PTEN mutations. In addition we define three phenotypic subgroups: (1) those cases associated with somatic overgrowth, (2) those with disproportionate macrocephaly, and (3) those will relative macrocephaly. We have devised a novel way to segregate patients into these subgroups that will aide in the stratification of autism macrocephaly cases. Within these subgroups, we further expand the genetic etiologies for autism cases with macrocephaly by describing two novel suspected pathogenic Copy Number Variants (CNVs) located at 6q23.2 and 10q24.32. These findings demonstrate the phenotypic heterogeneity of autism cases associated with macrocephaly and their genetic etiologies. The clinical yield from PTEN mutation analysis is 22% and 9% from Chromosomal Microarray (CMA) testing within this cohort. The identification of three distinct phenotypic subgroups within macrocephaly autism patients may allow for the identification of their respective distinct genetic etiologies which to date have remained elusive.
登录
查看更多内容
影响因子:
3.7
作者:
Bruining H;de Sonneville L;Swaab H;de Jonge M;Kas M;van Engeland H;Vorstman J
通讯作者:
Vorstman J
DOI:
10.1097/gim.0b013e3181f8baad
发表时间:
2010-11
期刊:
Genetics in medicine : official journal of the American College of Medical Genetics
影响因子:
--
作者:
Manning M;Hudgins L;Professional Practice and Guidelines Committee
通讯作者:
Professional Practice and Guidelines Committee
DOI:
10.1002/ajmg.b.30729
发表时间:
2008-10-05
影响因子:
2.8
作者:
Kent, Lindsey;Bowdin, Sarah;Maher, Eamonn R.
通讯作者:
Maher, Eamonn R.
影响因子:
8.8
作者:
Rosenfeld, Jill A.;Ballif, Blake C.;Shaffer, Lisa G.
通讯作者:
Shaffer, Lisa G.
影响因子:
3.7
作者:
Hu VW;Addington A;Hyman A
通讯作者:
Hyman A